Brief: NextCure And LegoChem Biosciences Enter Into Collaboration
15/11/2022 22:13
Nov 15 (Reuters) - LegoChem Biosciences Inc 141080.KQ :
* NEXTCURE AND LEGOCHEM BIOSCIENCES ENTER INTO COLLABORATION
AND
CO-DEVELOPMENT AGREEMENT TO DEVELOP ANTIBODY DRUG CONJUGATES
Source text for Eikon: ID:nGNX2nWm8X
Further company coverage: 141080.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LigaChem Biosciences
See all newsBrief: Ligachem Biosciences To Issue 170 Billion Won Worth Of Convertible Bonds
Brief: Ligachem Biosciences - Issues 2.21 Million New Preferred Shares
Brief: Ligachem Biosciences To Divest 5 Billion Won Worth Of Own Shares
Brief: Ligachem Biosciences To Divest 17 Billion Won Worth Of Own Shares
Brief: Legochem Biosciences To Conduct Capital Increase Of 470 Billion Won For Operational Funds